Incorporating biomarkers into clinical trial designs: points to consider.
Clinical Development, Oncology, MedImmune, Gaithersburg, Maryland, USA. bradleyed@Medimmune.com
Edward
E
Bradley
D014408:Biomarkers, Tumor; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
D014408:Biomarkers, Tumor